(Q36572534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Danish Mazhar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Justin Stebbing

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

509-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

A review and update on cholangiocarcinoma

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Epirubicin, cisplatin, and protracted infusion of 5-FU (ECF) in advanced intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II study of epirubicin, cisplatin, and capecitabine for advanced biliary tract adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Leucovorin, 5-fluorouracil, and gemcitabine: a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma: a North Central Cancer Treatment Group phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.2.4.509

21 January 2018

Identifiers

DOI

10.2217/14796694.2.4.509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16922617%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference